Merge Healthcare, an IBM Company

Health Technology

L2Mtech | February 17, 2021

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent S...

Medical Devices

GeneQuantum Healthcare | May 16, 2022

GeneQuantum Healthcare Co., Ltd. a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum's pipelines in the clinical stage. They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugateboth with global intellectual property r...

Health Technology

Johnson & Quin | November 10, 2020

Johnson and Quin, a full-administration regular postal mail creation and mailing administrations organization, has effectively accomplished the HIPAA Security Compliance Assessment which guarantees their elevated level of security and capacity to deliver medical care and related standard mail programs. Notwithstanding HIPAA they have additionally finished their third yearly System and Organizational Controls (SOC) 2 Typ...

Health Technology

Medtronic | July 15, 2022

Medtronic plc a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration clearance for its UNiD™ Spine Analyzer v4.0 planning platform, which includes a new Degen Algorithm for degenerative spine procedures. The algorithm leverages machine learning to help surgeons plan and personalize procedures for patients undergoing lower lumbar spine surgery and predicts spinal compensation mechanisms six months after the operation. This new upda...